APA

Westermann J., Hecker A., Flörcken A., Dörken B. & Pezzutto A. (20091005). Granulocyte macrophage-colony stimulating factor plus interleukin-2 plus alpha-interferon plus 5-fluorouracil in the treatment of metastatic renal cell cancer: induction of CD80/86+ T cells indicates adverse outcome. : Journal of immunotherapy (Hagerstown, Md. : 1997).

Chicago

Westermann Jörg, Hecker Ann-Christine, Flörcken Anne, Dörken Bernd and Pezzutto Antonio. 20091005. Granulocyte macrophage-colony stimulating factor plus interleukin-2 plus alpha-interferon plus 5-fluorouracil in the treatment of metastatic renal cell cancer: induction of CD80/86+ T cells indicates adverse outcome. : Journal of immunotherapy (Hagerstown, Md. : 1997).

Harvard

Westermann J., Hecker A., Flörcken A., Dörken B. and Pezzutto A. (20091005). Granulocyte macrophage-colony stimulating factor plus interleukin-2 plus alpha-interferon plus 5-fluorouracil in the treatment of metastatic renal cell cancer: induction of CD80/86+ T cells indicates adverse outcome. : Journal of immunotherapy (Hagerstown, Md. : 1997).

MLA

Westermann Jörg, Hecker Ann-Christine, Flörcken Anne, Dörken Bernd and Pezzutto Antonio. Granulocyte macrophage-colony stimulating factor plus interleukin-2 plus alpha-interferon plus 5-fluorouracil in the treatment of metastatic renal cell cancer: induction of CD80/86+ T cells indicates adverse outcome. : Journal of immunotherapy (Hagerstown, Md. : 1997). 20091005.